Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
BackgroundEnhancer RNAs (eRNAs) are intergenic long non-coding RNAs (lncRNAs) that participate in the progression of malignancies by targeting tumor-related genes and immune checkpoints. However, the potential role of eRNAs in hepatocellular carcinoma (HCC) is unclear. In this study, we aimed to con...
Main Authors: | Shenglan Cai, Xingwang Hu, Ruochan Chen, Yiya Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.657051/full |
Similar Items
-
Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma
by: Shanshan Lu, et al.
Published: (2021-04-01) -
Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties
by: Jialin Cai, et al.
Published: (2017-05-01) -
Development and validation of a RNA binding protein gene pair-associated prognostic signature for prediction of overall survival in hepatocellular carcinoma
by: Chunmiao Kang, et al.
Published: (2020-09-01) -
Development and External Validation of a Novel Immune Checkpoint–Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma
by: Enfa Zhao, et al.
Published: (2021-01-01) -
SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
by: Xiaozhen Peng, et al.
Published: (2021-03-01)